Pintova, S., Dharmupari, S., Moshier, E., Zubizarreta, N., Ang, C., & Holcombe, R. F. (2019). Genistein combined with FOLFOX or FOLFOX–Bevacizumab for the treatment of metastatic colorectal cancer: Phase I/II pilot study. Cancer chemotherapy and pharmacology, 84(3), 591-598. https://doi.org/10.1007/s00280-019-03886-3
Chicago Style (17th ed.) CitationPintova, Sofya, Sirish Dharmupari, Erin Moshier, Nicole Zubizarreta, Celina Ang, and Randall F. Holcombe. "Genistein Combined with FOLFOX or FOLFOX–Bevacizumab for the Treatment of Metastatic Colorectal Cancer: Phase I/II Pilot Study." Cancer Chemotherapy and Pharmacology 84, no. 3 (2019): 591-598. https://doi.org/10.1007/s00280-019-03886-3.
MLA (9th ed.) CitationPintova, Sofya, et al. "Genistein Combined with FOLFOX or FOLFOX–Bevacizumab for the Treatment of Metastatic Colorectal Cancer: Phase I/II Pilot Study." Cancer Chemotherapy and Pharmacology, vol. 84, no. 3, 2019, pp. 591-598, https://doi.org/10.1007/s00280-019-03886-3.